We are live on ! Find out more
FBC

Fairfield, Bush & Co Portfolio holdings

AUM $180M
1-Year Est. Return 39.51%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$368M
AUM Growth
+$17.6M
Cap. Flow
-$11.6M
Cap. Flow %
-3.15%
Top 10 Hldgs %
39.61%
Holding
168
New
6
Increased
49
Reduced
57
Closed
23

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.96M
2
AAPL icon
Apple
AAPL
+$1.91M
3
MSFT icon
Microsoft
MSFT
+$1.75M
4
ADSK icon
Autodesk
ADSK
+$1.66M
5
AMZN icon
Amazon
AMZN
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 26.51%
2 Healthcare 17.25%
3 Consumer Discretionary 12.52%
4 Consumer Staples 11.07%
5 Communication Services 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
151
MetLife
MET
$62.3B
-6,000
Closed -$365K
MRNA icon
152
Moderna
MRNA
$22.1B
-4,000
Closed -$524K
PYPL icon
153
PayPal
PYPL
$49B
-2,000
Closed -$486K
QLYS icon
154
Qualys
QLYS
$5.09B
-2,410
Closed -$253K
SAGE
155
DELISTED
Sage Therapeutics
SAGE
-5,000
Closed -$374K
TDOC icon
156
Teladoc Health
TDOC
$1.24B
-1,400
Closed -$254K
TRMB icon
157
Trimble
TRMB
$13.3B
-3,000
Closed -$233K
TWLO icon
158
Twilio
TWLO
$29.7B
-2,500
Closed -$852K
UPS icon
159
United Parcel Service
UPS
$88.6B
-2,500
Closed -$425K
SPLK
160
DELISTED
Splunk Inc
SPLK
-8,500
Closed -$1.15M

Similar funds

Fairfield, Bush & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Fairfield, Bush & Co held 168 positions worth $368M, up 5% from $350M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fairfield, Bush & Co withdrew a net $11.6M in Q2 2021, closing 23 positions and reducing 57 holdings. Its most notable exit was Biogen, an estimated $1.96M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fairfield, Bush & Co opened a new position in Albemarle worth $628K.

  • Fairfield, Bush & Co's largest Q2 2021 buy was Albemarle: 3,730 shares worth $628K.
  • Fairfield, Bush & Co added most to iShares 1-3 Year Treasury Bond ETF in Q2 2021, an estimated $3.27M increase.
  • Fairfield, Bush & Co's biggest Q2 2021 reduction was Apple, cutting an estimated $1.91M.
  • Fairfield, Bush & Co fully exited Biogen in Q2 2021, selling an estimated $1.96M.
  • Fairfield, Bush & Co's ten largest holdings make up 40% of its $368M portfolio in Q2 2021.
  • Fairfield, Bush & Co opened 6 new positions and closed 23 in Q2 2021.
  • Fairfield, Bush & Co's portfolio value rose 5% quarter-over-quarter to $368M.

Based on Fairfield, Bush & Co's 13F filing for Q2 2021, filed 2 Aug 2021.